{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:33:46Z","timestamp":1793745226153,"version":"4.6.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1245\/s10434-025-18806-4","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T15:12:58Z","timestamp":1765465978000},"page":"3535-3544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Surgical Challenges Associated with Collateral Veins Formation in Pancreatic Cancer with Vein Resection"],"prefix":"10.1245","volume":"33","author":[{"given":"Tatsunori","family":"Miyata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7315-0830","authenticated-orcid":false,"given":"Atsushi","family":"Oba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomotaka","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Ozaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sasahira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Matsueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"11","key":"18806_CR1","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu HM, Ahmed KY, Kibret GD, et al. Global Disparities of Cancer and Its Projected Burden in 2050. JAMA Netw Open. 2024;7(11):e2443198.","journal-title":"JAMA Netw Open"},{"issue":"19","key":"18806_CR2","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","volume":"364","author":"T Conroy","year":"2011","unstructured":"Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817\u201325.","journal-title":"N Engl J Med"},{"issue":"18","key":"18806_CR3","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691\u2013703.","journal-title":"N Engl J Med"},{"key":"18806_CR4","doi-asserted-by":"crossref","unstructured":"Henault D, Kunde H, Zatzman C et al. Vascular Resection for Pancreas Cancer - 10-year Experience from a Single High Volume-center. Ann Surg 2024 Oct 16. Online ahead of print.","DOI":"10.1097\/SLA.0000000000006567"},{"key":"18806_CR5","doi-asserted-by":"crossref","unstructured":"Kinny-K\u00f6ster B, Lambrecht A, Flossmann V et al. Alloplastic Vascular Grafts for Venous Interposition in Pancreatic Surgery: Readily Available and Reliable. Ann Surg 2024 Nov 7. Online ahead of print.","DOI":"10.1097\/SLA.0000000000006581"},{"issue":"6","key":"18806_CR6","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.surg.2020.07.054","volume":"168","author":"B Kinny-K\u00f6ster","year":"2020","unstructured":"Kinny-K\u00f6ster B, van Oosten F, Habib JR, et al. Mesoportal bypass, interposition graft, and mesocaval shunt: Surgical strategies to overcome superior mesenteric vein involvement in pancreatic cancer. Surgery. 2020;168(6):1048\u201355.","journal-title":"Surgery"},{"issue":"3","key":"18806_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/bjs5.50268","volume":"4","author":"A Oba","year":"2020","unstructured":"Oba A, Ito H, Ono Y, et al. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion. BJS Open. 2020;4(3):438\u201348.","journal-title":"BJS Open"},{"issue":"3","key":"18806_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.surg.2013.09.003","volume":"155","author":"P Bachellier","year":"2014","unstructured":"Bachellier P, Rosso E, Fuchshuber P, et al. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension. Surgery. 2014;155(3):449\u201356.","journal-title":"Surgery"},{"issue":"11","key":"18806_CR9","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.hpb.2024.07.408","volume":"26","author":"JM Harrison","year":"2024","unstructured":"Harrison JM, Li AY, Bergquist JR, et al. Revascularization techniques for complete portomesenteric venous occlusion in patients undergoing pancreatic resection. HPB (Oxford). 2024;26(11):1411\u201320.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"18806_CR10","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/ags3.12795","volume":"8","author":"M Miyashita","year":"2024","unstructured":"Miyashita M, Yoshioka R, Fukumura Y, et al. Low incidence of pancreatic fistula and well-preserved endocrine function with non-reconstructed small remnant pancreas after pancreaticoduodenectomy. Ann Gastroenterol Surg. 2024;8(5):860\u20137.","journal-title":"Ann Gastroenterol Surg"},{"issue":"8","key":"18806_CR11","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.1245\/s10434-023-13534-z","volume":"30","author":"Y Kitano","year":"2023","unstructured":"Kitano Y, Inoue Y, Takeda T, et al. Clinical Efficacy of Neoadjuvant Chemotherapy with Gemcitabine plus S-1 for Resectable Pancreatic Ductal Adenocarcinoma Compared with Upfront Surgery. Ann Surg Oncol. 2023;30(8):5093\u2013102.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"18806_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/jhbp.844","volume":"28","author":"Y Inoue","year":"2021","unstructured":"Inoue Y, Saiura A, Oba A, et al. Neoadjuvant gemcitabine and nab-paclitaxel for borderline resectable pancreatic cancers: Intention-to-treat analysis compared with upfront surgery. J Hepatobiliary Pancreat Sci. 2021;28(2):143\u201355.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"5","key":"18806_CR13","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s00268-022-06457-5","volume":"46","author":"N Kuroki","year":"2022","unstructured":"Kuroki N, Ono Y, Sato T, et al. Long-Term Outcome of Patients with Postoperative Refractory Diarrhea After Tailored Nerve Plexus Dissection Around the Major Visceral Arteries During Pancreatoduodenectomy for Pancreatic Cancer. World J Surg. 2022;46(5):1172\u201382.","journal-title":"World J Surg"},{"issue":"5","key":"18806_CR14","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.surg.2022.10.025","volume":"173","author":"K Kobayashi","year":"2023","unstructured":"Kobayashi K, Ono Y, Sato S, et al. Evaluation of local recurrence after pancreaticoduodenectomy for borderline resectable pancreatic head cancer with neoadjuvant chemotherapy: Can the resection level change after chemotherapy? Surgery. 2023;173(5):1220\u20138.","journal-title":"Surgery"},{"issue":"8","key":"18806_CR15","doi-asserted-by":"publisher","first-page":"5038","DOI":"10.1245\/s10434-022-11503-6","volume":"29","author":"Y Ushida","year":"2022","unstructured":"Ushida Y, Inoue Y, Oba A, et al. Optimizing Indications for Conversion Surgery Based on Analysis of 454 Consecutive Japanese Cases with Unresectable Pancreatic Cancer Who Received Modified FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel: A Single-Center Retrospective Study. Ann Surg Oncol. 2022;29(8):5038\u201350.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"18806_CR16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s11605-018-3995-3","volume":"23","author":"Y Inoue","year":"2019","unstructured":"Inoue Y, Saiura A, Oba A, et al. Optimal Extent of Superior Mesenteric Artery Dissection during Pancreaticoduodenectomy for Pancreatic Cancer: Balancing Surgical and Oncological Safety. J Gastrointest Surg. 2019;23(7):1373\u201383.","journal-title":"J Gastrointest Surg"},{"issue":"10041","key":"18806_CR17","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0140-6736(16)30583-9","volume":"388","author":"K Uesaka","year":"2016","unstructured":"Uesaka K, Boku N, Fukutomi A, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388(10041):248\u201357.","journal-title":"Lancet"},{"key":"18806_CR18","unstructured":"Pancreatic adenocarcinoma (version 1.2024). . https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf."},{"issue":"10","key":"18806_CR19","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.hpb.2023.05.366","volume":"25","author":"Y Kazami","year":"2023","unstructured":"Kazami Y, Oba A, Ono Y, et al. Intraoperative paraaortic lymph node sampling during resection for pancreatic cancer: evolving role in the modern chemotherapy era. HPB (Oxford). 2023;25(10):1169\u201378.","journal-title":"HPB (Oxford)"},{"issue":"6","key":"18806_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1097\/SLA.0000000000001065","volume":"262","author":"Y Inoue","year":"2015","unstructured":"Inoue Y, Saiura A, Yoshioka R, et al. Pancreatoduodenectomy With Systematic Mesopancreas Dissection Using a Supracolic Anterior Artery-first Approach. Ann Surg. 2015;262(6):1092\u2013101.","journal-title":"Ann Surg"},{"issue":"5","key":"18806_CR21","first-page":"913","volume":"108","author":"A Nakao","year":"1990","unstructured":"Nakao A, Nonami T, Harada A, et al. Portal vein resection with a new antithrombogenic catheter. Surgery. 1990;108(5):913\u20138.","journal-title":"Surgery"},{"issue":"5","key":"18806_CR22","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.21037\/jgo-21-129","volume":"12","author":"A Oba","year":"2021","unstructured":"Oba A, Kato T, Inoue Y, et al. Extent of venous resection during pancreatectomy-finding the balance of technical possibility and feasibility. J Gastrointest Oncol. 2021;12(5):2495\u2013502.","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"18806_CR23","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pan.2025.01.007","volume":"25","author":"A Oba","year":"2025","unstructured":"Oba A, Tanaka K, Inoue Y, et al. Pancreatectomies with vein resection: Two large institutions\u2019 experience of East and West. Pancreatology. 2025;25(2):250\u20137.","journal-title":"Pancreatology"},{"issue":"21","key":"18806_CR24","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.3390\/cancers13215334","volume":"13","author":"Y Ono","year":"2021","unstructured":"Ono Y, Inoue Y, Kato T, et al. Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention. Cancers (Basel). 2021;13(21):5334.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"18806_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12893-018-0420-5","volume":"18","author":"S Kawakatsu","year":"2018","unstructured":"Kawakatsu S, Inoue Y, Mise Y, et al. Comparison of pancreatojejunostomy techniques in patients with a soft pancreas: Kakita anastomosis and Blumgart anastomosis. BMC Surg. 2018;18(1):88.","journal-title":"BMC Surg"},{"issue":"2","key":"18806_CR26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205\u201313.","journal-title":"Ann Surg"},{"issue":"2","key":"18806_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11605-011-1733-1","volume":"16","author":"MM Assifi","year":"2012","unstructured":"Assifi MM, Lindenmeyer J, Leiby BE, et al. Surgical Apgar score predicts perioperative morbidity in patients undergoing pancreaticoduodenectomy at a high-volume center. J Gastrointest Surg. 2012;16(2):275\u201381.","journal-title":"J Gastrointest Surg"},{"issue":"5","key":"18806_CR28","doi-asserted-by":"publisher","first-page":"e1081","DOI":"10.1097\/SLA.0000000000005330","volume":"277","author":"Y Nagakawa","year":"2023","unstructured":"Nagakawa Y, Jang JY, Kawai M, et al. Surgical Outcomes of Pancreatectomy with Resection of the Portal Vein and\/or Superior Mesenteric Vein and Jejunal Vein for Pancreatic Head Cancer: A Multicenter Study. Ann Surg. 2023;277(5):e1081\u20138.","journal-title":"Ann Surg"},{"key":"18806_CR29","unstructured":"National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma, version 2.2025. NCCN: 2025."},{"issue":"2","key":"18806_CR30","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jss.2015.03.028","volume":"198","author":"CK Yang","year":"2015","unstructured":"Yang CK, Teng A, Lee DY, et al. Pulmonary complications after major abdominal surgery: National Surgical Quality Improvement Program analysis. J Surg Res. 2015;198(2):441\u20139.","journal-title":"J Surg Res"},{"issue":"5","key":"18806_CR31","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1378\/chest.69.5.621","volume":"69","author":"RW Light","year":"1976","unstructured":"Light RW, George RB. Incidence and significance of pleural effusion after abdominal surgery. Chest. 1976;69(5):621\u20135.","journal-title":"Chest"},{"key":"18806_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jss.2023.11.010","volume":"295","author":"AA Smith","year":"2024","unstructured":"Smith AA, Cone JT, McNickle AG, et al. MultiCenter Study of Intra-Abdominal Abscess Formation After Major Operative Hepatic Trauma. J Surg Res. 2024;295:746\u201352.","journal-title":"J Surg Res"},{"issue":"12","key":"18806_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"CT Taylor","year":"2017","unstructured":"Taylor CT, Colgan SP. Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol. 2017;17(12):774\u201385.","journal-title":"Nat Rev Immunol"},{"key":"18806_CR34","first-page":"100809","volume":"35","author":"A Alaref","year":"2024","unstructured":"Alaref A, Siltamaki D, Cerasuolo JO, et al. Impact of pre-operative abdominal MRI on survival for patients with resected pancreatic carcinoma: a population-based study. Lancet Reg Health Am. 2024;35:100809.","journal-title":"Lancet Reg Health Am"},{"issue":"1","key":"18806_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.hpb.2024.10.011","volume":"27","author":"U Marchese","year":"2025","unstructured":"Marchese U, Lenne X, Naveendran G, et al. Nationwide analysis of one-year mortality following pancreatectomy in 17,183 patients with pancreatic cancer. HPB (Oxford). 2025;27(1):123\u20139.","journal-title":"HPB (Oxford)"},{"issue":"6","key":"18806_CR36","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jvir.2015.11.057","volume":"27","author":"U Scemama","year":"2016","unstructured":"Scemama U, Birnbaum DJ, Ouaissi M, et al. Portal Vein Stent Placement in Five Patients with Chronic Portal Vein Thrombosis Prior to Pancreatic Surgery. J Vasc Interv Radiol. 2016;27(6):889\u201394.","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"18806_CR37","doi-asserted-by":"publisher","first-page":"551","DOI":"10.14701\/ahbps.2020.24.4.551","volume":"24","author":"Y Kook","year":"2020","unstructured":"Kook Y, Choi M, Park JY, et al. Neoadjuvant chemotherapy followed by total pancreatectomy with splenectomy and combined vascular resections after preoperative percutaneous transhepatic portal vein stent placement in locally advanced pancreatic cancer with portal vein total obliteration. Ann Hepatobiliary Pancreat Surg. 2020;24(4):551\u20136.","journal-title":"Ann Hepatobiliary Pancreat Surg"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18806-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18806-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T15:48:34Z","timestamp":1773330514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18806-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["18806"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18806-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Atsushi Oba has been awarded a grant (Bayer Yakuhin, Ltd.) to conduct an observational study to investigate the clinical impact of EOB-MRI. Masato Ozaka declares relevant financial activities outside the submitted work: Taiho, Yaklut Honsha, Ono, MSD, Novartis, Servier.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}